“PD-L1 Expression As a Predictor of Response to Neoadjuvant Immunotherapy in Triple-Negative Breast Cancer”. 2026. Journal of Evidence-Based Medical Research 2 (03): 58-69. https://doi.org/10.66687/jebmr.2.03.2026.43.